Home»News»Study: Cannabinoid Could Potentially Cut Down On NSAID-Induced Hospitalizations

Study: Cannabinoid Could Potentially Cut Down On NSAID-Induced Hospitalizations

NSAIDs (non-steroidal anti-inflammatory drugs such as ibuprofren) are among the most widely used analgesic substances in the world. However, the consumption of these products is associated with various adverse and life-threatening side-effects such as heart-attack, stroke, and internal bleeding. In fact, according to a 2001 analysis, in the United States alone, “gastrointestinal complications induced by nonsteroidal anti-inflammatory drugs (NSAIDs) cause more than 100,000 hospitalizations and an estimated 16,500 deaths annually.”

Read More: http://blog.norml.org/2013/06/20/study-cannabinoid-could-potentially-cut-down-on-nsaid-induced-hospitalizations/

The following two tabs change content below.

Stephen Carter

Stephen Carter is a journalist and information technology specialist living in Waco, Texas. He has been working with the cannabis movement since 2009. He founded Texas Cannabis Report in 2013 to bring Texans accurate cannabis related news.

Latest posts by Stephen Carter (see all)



Previous post

Study: Cannabis Compound Reduces Cigarette Consumption In Tobacco Smokers

Next post

Study: Cannabis Smoking Not Associated With Increased Lung Cancer Risk Or Other Serious Pulmonary Complications